> top > docs > PubMed:9398087 > annotations

PubMed:9398087 JSONTXT

Annnotations TAB JSON ListView MergeView

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 317-329 Cell denotes granulocytic http://purl.obolibrary.org/obo/CL:0000094
T2 810-823 Cell denotes promyelocytic http://purl.obolibrary.org/obo/CL:0000836
T3 1254-1267 Cell denotes promyelocytic http://purl.obolibrary.org/obo/CL:0000836

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 97-125 cell_type denotes human myeloid leukemia cells
T2 252-280 cell_type denotes human myeloid leukemia cells
T3 349-360 cell_line denotes HL-60 cells
T4 563-582 cell_line denotes HL-60 and NB4 cells
T5 769-783 cell_type denotes leukemia cells

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-157 Sentence denotes Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
S2 158-281 Sentence denotes Differanisole A, 3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid, inhibited growth of human myeloid leukemia cells.
S3 282-418 Sentence denotes The compound induced G1 arrest and granulocytic differentiation of HL-60 cells, although the differentiation-inducing effect was modest.
S4 419-716 Sentence denotes Differanisole A and 9-cis retinoic acid (9cisRA) synergistically inhibited the growth and induced functional and morphologic differentiation of HL-60 and NB4 cells, whereas the combined treatment with differanisole A and all-trans retinoic acid or 1alpha,25-dihydroxyvitamin D3 was less effective.
S5 717-833 Sentence denotes Similar results were obtained in primary culture of leukemia cells from a patient with acute promyelocytic leukemia.
S6 834-975 Sentence denotes The synergistic effect on growth inhibition and induction of differentiation required simultaneous treatment with differanisole A and 9cisRA.
S7 976-1167 Sentence denotes Differanisole A and an RXR-specific ligand (Ro47-5944) cooperatively inhibited the cell growth, while the combined effect of differanisole A and an RAR-specific ligand Am80 was just additive.
S8 1168-1286 Sentence denotes Differanisole A in combination with 9cisRA may have implications for therapy of acute promyelocytic leukemia patients.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-15 NP denotes Differanisole A
C2 17-45 NP denotes a novel antitumor antibiotic
C3 97-125 NP denotes human myeloid leukemia cells
C4 137-156 NP denotes 9-cis retinoic acid
C5 158-173 NP denotes Differanisole A
C6 175-230 NP denotes 3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid
C7 252-280 NP denotes human myeloid leukemia cells
C9 419-434 NP denotes Differanisole A
C10 439-467 NP denotes 9-cis retinoic acid (9cisRA)
C8 419-467 NP denotes Differanisole A and 9-cis retinoic acid (9cisRA)
C11 620-635 NP denotes differanisole A
C12 789-832 NP denotes a patient with acute promyelocytic leukemia
C14 948-963 NP denotes differanisole A
C15 968-974 NP denotes 9cisRA
C13 948-974 NP denotes differanisole A and 9cisRA
C16 976-991 NP denotes Differanisole A
C17 1101-1116 NP denotes differanisole A
C18 1168-1183 NP denotes Differanisole A
C19 1204-1210 NP denotes 9cisRA
C20 1248-1285 NP denotes acute promyelocytic leukemia patients
R1 C2 C1 coref-appos a novel antitumor antibiotic,Differanisole A
R2 C5 C1 coref-ident Differanisole A,Differanisole A
R3 C6 C5 coref-appos "3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid",Differanisole A
R4 C7 C3 coref-ident human myeloid leukemia cells,human myeloid leukemia cells
R5 C9 C5 coref-ident Differanisole A,Differanisole A
R6 C10 C4 coref-ident 9-cis retinoic acid (9cisRA),9-cis retinoic acid
R7 C11 C9 coref-ident differanisole A,Differanisole A
R8 C14 C11 coref-ident differanisole A,differanisole A
R9 C15 C10 coref-ident 9cisRA,9-cis retinoic acid (9cisRA)
R10 C13 C8 coref-ident differanisole A and 9cisRA,Differanisole A and 9-cis retinoic acid (9cisRA)
R11 C16 C14 coref-ident Differanisole A,differanisole A
R12 C17 C16 coref-ident differanisole A,Differanisole A
R13 C18 C17 coref-ident Differanisole A,differanisole A
R14 C19 C15 coref-ident 9cisRA,9cisRA
R15 C20 C12 coref-ident acute promyelocytic leukemia patients,a patient with acute promyelocytic leukemia

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-15 other_organic_compound denotes Differanisole A
T2 25-45 other_organic_compound denotes antitumor antibiotic
T3 97-125 cell_type denotes human myeloid leukemia cells
T4 137-156 other_organic_compound denotes 9-cis retinoic acid
T5 158-173 other_organic_compound denotes Differanisole A
T6 175-230 other_organic_compound denotes 3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid
T7 252-280 cell_type denotes human myeloid leukemia cells
T8 303-312 other_name denotes G1 arrest
T9 317-345 other_name denotes granulocytic differentiation
T10 349-360 cell_line denotes HL-60 cells
T11 419-434 other_organic_compound denotes Differanisole A
T12 439-458 other_organic_compound denotes 9-cis retinoic acid
T13 460-466 other_organic_compound denotes 9cisRA
T14 620-635 other_organic_compound denotes differanisole A
T15 640-663 other_organic_compound denotes all-trans retinoic acid
T16 667-696 other_organic_compound denotes 1alpha,25-dihydroxyvitamin D3
T17 769-783 cell_type denotes leukemia cells
T18 804-832 other_name denotes acute promyelocytic leukemia
T19 948-963 other_organic_compound denotes differanisole A
T20 968-974 other_organic_compound denotes 9cisRA
T21 976-991 other_organic_compound denotes Differanisole A
T22 999-1018 other_organic_compound denotes RXR-specific ligand
T23 1020-1029 other_organic_compound denotes Ro47-5944
T24 1101-1116 other_organic_compound denotes differanisole A
T25 1124-1143 other_organic_compound denotes RAR-specific ligand
T26 1144-1148 other_organic_compound denotes Am80
T27 1168-1183 other_organic_compound denotes Differanisole A
T28 1204-1210 other_organic_compound denotes 9cisRA
T29 1248-1276 other_name denotes acute promyelocytic leukemia

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 103-119 Phenotype denotes myeloid leukemia HP:0012324
T2 258-274 Phenotype denotes myeloid leukemia HP:0012324
T3 769-777 Phenotype denotes leukemia HP:0001909
T4 804-832 Phenotype denotes acute promyelocytic leukemia HP:0004836
T5 1248-1276 Phenotype denotes acute promyelocytic leukemia HP:0004836

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 103-119 Disease denotes myeloid leukemia http://purl.obolibrary.org/obo/MONDO_0004643
T2 258-274 Disease denotes myeloid leukemia http://purl.obolibrary.org/obo/MONDO_0004643
T3 769-777 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T4 804-832 Disease denotes acute promyelocytic leukemia http://purl.obolibrary.org/obo/MONDO_0012883
T5 1248-1276 Disease denotes acute promyelocytic leukemia http://purl.obolibrary.org/obo/MONDO_0012883

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 97-102 OrganismTaxon denotes human 9606
T2 252-257 OrganismTaxon denotes human 9606
T3 791-798 OrganismTaxon denotes patient 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 317-329 Body_part denotes granulocytic http://purl.obolibrary.org/obo/CL_0000094